Prevalence of Ventilator-Associated Pneumonia (VAP) and Microbial Profile in ICU Settings
International Journal of Current Pharmaceutical Review and Research · 28.02.2026 · 18 (02)
DOI: 10.25258/ijcpr.18.2.285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 28.02.2026. Verfasst von Ahsan Hamidi und 4 weiteren Autor:innen.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections among patients receiving mechanical ventilation in intensive care units (ICUs). It contributes significantly to morbidity, mortality, and prolonged hospital stay. Understanding the prevalence and microbial profile of VAP is essential for effective infection control and appropriate antimicrobial therapy.
Objective
To determine the prevalence of ventilator-associated pneumonia and identify the microbial profile of pathogens responsible for VAP in ICU patients. Materials and Methods: A prospective observational study was conducted at Darbhanga Medical College and Hospital (DMCH), Bihar, India, over a period of one year from January 2024 to January 2025. A total of 110 patients admitted to ICU and requiring mechanical ventilation for more than 48 hours were included in the study. Endotracheal aspirate samples were collected for microbiological analysis. Data were analyzed using SPSS version 26. Statistical tests including chi-square and t-test were applied, with p < 0.05 considered statistically significant.
Results
Among the 110 ventilated patients, 34 developed ventilator-associated pneumonia, giving a prevalence of 30.9%. Gram-negative bacteria were the most frequently isolated pathogens. The most common organisms identified were Acinetobacter baumannii (26.5%), followed by Pseudomonas aeruginosa (23.5%) and Klebsiella pneumoniae (20.6%). Statistical analysis demonstrated a significant association between prolonged mechanical ventilation and VAP occurrence (p < 0.01).
Conclusion
The study revealed a high prevalence of ventilator-associated pneumonia in ICU patients, predominantly caused by gram-negative bacteria. Early diagnosis, surveillance of microbial patterns, and appropriate antibiotic stewardship are essential to reduce VAP-related morbidity and mortality.
Zitieren
APA
Hamidi, A., Sah, J. P., Kumar, D., Yasmin, T., & Jha, K. (2026). Prevalence of Ventilator-Associated Pneumonia (VAP) and Microbial Profile in ICU Settings. International Journal of Current Pharmaceutical Review and Research, 18(02). https://doi.org/10.25258/ijcpr.18.2.285
Vancouver
Hamidi A, Sah JP, Kumar D, Yasmin T, Jha K. Prevalence of Ventilator-Associated Pneumonia (VAP) and Microbial Profile in ICU Settings. International Journal of Current Pharmaceutical Review and Research. 2026;18(02). doi:10.25258/ijcpr.18.2.285
BibTeX
@article{Hamidi2026,
author = {Hamidi, Ahsan and Sah, Jibachh Prasad and Kumar, Dhirendra and Yasmin, Tarannum and Jha, Kanhaiya},
title = {Prevalence of Ventilator-Associated Pneumonia (VAP) and Microbial Profile in ICU Settings},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {02},
doi = {10.25258/ijcpr.18.2.285}
}
EUVIMED